ChinaBio生物医药产业合作大会

生物医药产业国际合作大会

2026年4月28-29日|上海浦东嘉里大酒店
2026年5月6-7日|线上
提交演讲申请

若您的研究涉及以下任一科学领域,我们诚邀您提交演讲申请。

我们特别征集涵盖以下方向的创新数据案例研究:

  • mAbs: Bispecific and Multispecific Antibodies
  • mAbs: Novel Techniques for Antibody Engineering
  • mAbs: Dual-specific Antibodies 
  • mAbs: Gated Antibodies 
  • mAbs: Novel Engineering Strategies to Avoid Toxicity of T-cell Engagers
     
    mAbs: Antibodies for Novel Targets 
  • mAbs: Preclinical and Clinical Updates on PD1/PDL1/VEGF Bispecifics 
  • mAbs: Antibodies for Autoimmune Diseases 
  • mAbs: Antibodies for Immunity and Inflammation 
  • ADCs: Novel ADC Payloads 
  • ADCs: Tumor-specific Release of Payloads 
  • ADCs: Multi-payloads for ADCs 
  • ADCs: Mechanisms of how ADCs work: Internalization, ADC tumor killing, Antigen Expression 
  • ADCs: Linker chemistry strategy (biology and chemistry) 
  • ADCs: Conditional Antibody Binding 
  • ADCs: Pharmacology and Mechanisms of ADCs: Metabolic Rate, Tumor Penetration 
  • ADCs: ADC Clinical Updates
  • ADCs: Innovations in ADC Manufacturing

演讲内容须避免商业倾向性,且不得涉及任何商业产品与服务的推介。所有入选的演讲嘉宾均须披露其是否存在重大财务利益。相关财务利益关系可能影响您演讲提案的评审结果。

组委会评审团队将在遴选完成后通知入选结果。

*请用英文完成申请

If you are interested in receiving sponsor or exhibitor information about this conference, please check this box.